Home
>
National Drug Code (NDC)
>
Brimonidine
Brimonidine - 17478-715-11 - (Brimonidine Tartrate)
Drug Information of Brimonidine
| Product NDC: | 17478-715 |
| Proprietary Name: | Brimonidine |
| Non Proprietary Name: | Brimonidine Tartrate |
| Active Ingredient(s): | 2 mg/mL & nbsp; Brimonidine Tartrate |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Brimonidine
| Product NDC: | 17478-715 |
| Labeler Name: | Akorn, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076439 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060907 |
Package Information of Brimonidine
| Package NDC: | 17478-715-11 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (17478-715-11) > 10 mL in 1 BOTTLE, DROPPER |
NDC Information of Brimonidine
| NDC Code | 17478-715-11 |
| Proprietary Name | Brimonidine |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (17478-715-11) > 10 mL in 1 BOTTLE, DROPPER |
| Product NDC | 17478-715 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Brimonidine Tartrate |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20060907 |
| Marketing Category Name | ANDA |
| Labeler Name | Akorn, Inc. |
| Substance Name | BRIMONIDINE TARTRATE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
